Resource Center
Resource Center
Our monthly checkin with staff. Learn more about the people who work at CHAI.
Read more
The report provides an overview of the supplier landscape for WHO recommended drugs and diagnostics, outlines supply and pricing trends, highlights global benchmark prices, and suggests ways in which low- and middle-income countries can access testing and treatment at more affordable prices.
Read more
AVAC, CHAI and others are making sure we can introduce a new HIV prevention injection quickly and safely after early results from a clinical trial.
Read more
CHAI’s HIV Mid-Year Market Memo covers the latest trends in the HIV space in low- and middle-income countries since the publication of our HIV Market Report in September 2019.
Read more
CHAI works with governments across more than 10 countries to build the capacity of midwives and skilled birth attendants – during the coronavirus pandemic and beyond.
Read more
CEO Iain Barton chats about CHAI's COVID-19 response, what he is bringing to the organization, and setting “big, hairy, audacious goals” for the future.
Read more
Agreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.
Read more
Beginning on April 28, 2020, CHAI and Unitaid will begin accepting Expressions of Interest (EOI) and admitting selected partners to the EMAV on a rolling basis through September 30, 2021 (or when maximum volume commitment is delivered).
Read more
Preclinical work in mice and primates has demonstrated that a single injection of a new drug developed by UNMC is effective in achieving blood drug levels known to be active against HIV for up to one year.
Read more
Cambodia plans to eliminate malaria by 2025. A network of volunteers in hard-to-reach communities is key to making it happen.
Read more